fy2025

GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net profit: US$230.3 million, +285.0% year-on-yearBusiness Units' PerformanceGenScript Life…

6 days ago

Titomic – Driving Innovation and Securing the Future in FY2025

HUNTSVILLE, Ala., Aug. 27, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global leader in advanced additive manufacturing and cold spray…

7 months ago

LOCKTON SURPASSES $4 BILLION IN FY2025 REVENUE, DRIVEN BY INDUSTRY-LEADING ORGANIC GROWTH AND RELENTLESS FOCUS ON CLIENTS

Global alignment and executive appointments fuel Lockton's fifth straight year of double-digit organic growth KANSAS CITY, Mo., June 16, 2025…

9 months ago